[On the pharmacology of olemorphocycline].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D001001:Anura; D001794:Blood Pressure / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D002923:Cilia / Q000187:drug effects; D003864:Depression, Chemical; D004285:Dogs; D004848:Epithelium / Q000187:drug effects; D005223:Fats / Q000032:analysis; D007249:Inflammation / Q000139:chemically induced; D008099:Liver / Q000032:analysis; D051379:Mice; D009132:Muscles / Q000187:drug effects; D009827:Oleandomycin / Q000494:pharmacology* / Q000633:toxicity; D011817:Rabbits; D051381:Rats; D012119:Respiration / Q000187:drug effects; D013752:Tetracycline / Q000494:pharmacology* / Q000633:toxicity; D014665:Vasodilator Agents / Q000494:pharmacology; D014680:Veins / Q000187:drug effects
D000900:Anti-Bacterial Agents; D005223:Fats; D014665:Vasodilator Agents; D013752:Tetracycline; D009827:Oleandomycin
K farmakologii olemorfotsiklina.